Terms: = Leukemia AND ER, estrogen receptor AND Clinical Outcome
11 results:
1. Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
Hoff FW; Qiu Y; Brown BD; Gerbing RB; Leonti AR; Ries RE; Gamis AS; Aplenc R; Kolb EA; Alonzo TA; Meshinchi S; Jenkins GN; Horton TM; Kornblau SM
Proteomics Clin Appl; 2023 Nov; 17(6):e2200109. PubMed ID: 37287368
[TBL] [Abstract] [Full Text] [Related]
2. Rebound lymphocytosis in a patient with chronic lymphocytic leukemia after cessation of a CDK 4/6 inhibitor for concomitant breast cancer.
Doucette K; Lai C; Pohlmann PR
Breast J; 2020 Oct; 26(10):2031-2033. PubMed ID: 32639043
[TBL] [Abstract] [Full Text] [Related]
3. WDR5 Expression Is Prognostic of Breast Cancer outcome.
Dai X; Guo W; Zhan C; Liu X; Bai Z; Yang Y
PLoS One; 2015; 10(9):e0124964. PubMed ID: 26355959
[TBL] [Abstract] [Full Text] [Related]
4. ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinoma.
Yeo SY; Ha SY; Yu EJ; Lee KW; Kim JH; Kim SH
Oncotarget; 2014 Dec; 5(23):12260-72. PubMed ID: 25373738
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy.
Choi JE; Kang SH; Lee SJ; Bae YK
Tumour Biol; 2014 Dec; 35(12):12255-63. PubMed ID: 25179840
[TBL] [Abstract] [Full Text] [Related]
6. Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer.
Ferrari N; Mohammed ZM; Nixon C; Mason SM; Mallon E; McMillan DC; Morris JS; Cameron ER; Edwards J; Blyth K
PLoS One; 2014; 9(6):e100759. PubMed ID: 24967588
[TBL] [Abstract] [Full Text] [Related]
7. Novel players in multiple myeloma pathogenesis: role of protein kinases CK2 and GSK3.
Piazza F; Manni S; Semenzato G
Leuk Res; 2013 Feb; 37(2):221-7. PubMed ID: 23174190
[TBL] [Abstract] [Full Text] [Related]
8. Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and leukemia Group B 40101.
Shulman LN; Cirrincione CT; Berry DA; Becker HP; Perez EA; O'Regan R; Martino S; Atkins JN; Mayer E; Schneider CJ; Kimmick G; Norton L; Muss H; Winer EP; Hudis C
J Clin Oncol; 2012 Nov; 30(33):4071-6. PubMed ID: 22826271
[TBL] [Abstract] [Full Text] [Related]
9. How different are luminal A and basal breast cancers?
Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Buttarelli M; Jacquemier J; Chaffanet M; Maraninchi D; Viens P; Birnbaum D
Int J Cancer; 2009 Mar; 124(6):1338-48. PubMed ID: 19058218
[TBL] [Abstract] [Full Text] [Related]
10. [Treatment of acute lymphoblastic leukemia by autologous stem cell transplantation: an analysis of 30 cases].
Zou D; Han M; Feng S; Li C; Qiu L; Jiang R; Han J; Wang M; Zhang L; Han Z; Yan W
Zhonghua Xue Ye Xue Za Zhi; 2000 Feb; 21(2):74-6. PubMed ID: 11876962
[TBL] [Abstract] [Full Text] [Related]
11. [outcome of autologous bone marrow transplantation in 73 patients with acute leukemia].
Han M; Feng S; Li C
Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):422-4. PubMed ID: 11189510
[TBL] [Abstract] [Full Text] [Related]
